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Electronic and optical properties of 5-AVA-
functionalized BN nanoclusters: a DFT study
Alireza Soltani,*a Ahmad Sousaraei,a Masoud Bezi Javan,b Mortaza Eskandaric and
Hanzaleh Balakheylid
We carried out detailed density functional theory (DFT) and time-dependent density functional theory
(TD-DFT) calculations upon 5-aminolevulinic acid-functionalized B12N12 and B16N16 nanoclusters with
the B3LYP, B3PW91, and PBE methods using the 6-311+G** basis set. The calculated adsorption
energies of 5-aminolevulinic acid with the BN nanoclusters were evaluated at T = 298.15 and 311.15 K in
the gaseous and aqueous environments with the B3LYP, B3PW91, and PBE methods. Our results showed
that the adsorption of the 5-AVA molecule (NH2 group) with B12N12 is more favorable than – with the
B16N16 nanocluster in the gas and solvent phases. It is anticipated that a 5-aminolevulinic acid (5-AVA)
drug incorporating BN clusters could find application in drug delivery systems and in biomedical devices.
1. Introduction
Bioconjugated nanostructured materials have become visible
as novel materials for medical diagnostics and biosensing
applications in recent years,1,2 for example, pristine BN nano-
structures are recognized as promising candidates for such
applications. Boron nitride nanotubes (BNNTs), a morpho-
logically similar prototype of carbon nanotubes (CNTs) with
diﬀerent properties of their own, for instance with the capabil-
ities of uniformity and stability in dispersion in solution, are
known as particularly promising candidates for biomedical
applications.3–6 Their electronic structures and properties vary
widely owing to the tube helicity and concentric layers, unlike
CNTs, and their semiconducting properties, regardless of their
diameter and chirality, which make these materials suitable for
electronic applications.7,8 BNNTs are renowned as nontoxic
materials to health and the environment owing to their
chemical inertness and structural stability, and hence, they
are useful in the development of drug delivery systems, novel
biosensors, biofunctional materials, nanovectors for cell therapy,
and gene delivery studies.9–13 Within the hemechromophore in
the mitochondria is a compound called 5-aminolevulinic acid
(5-AVA), which is considered to be a key synthetic building block
in protoporphyrin IX (PpIX). Under the negative feedback control
mechanism of heme, ALA could be synthesized in mitochondria.
Basically, the mechanism is initiated by the building of glycine
and succinyl CoA, with this being catalyzed via ALA-syntase,
making this the first intermediate synthesizing agent that under-
goes a series of biochemical reactions. Consequently, in the
presence of iron, PpIX is converted into heme by ferrochelatase.
A great deal of attention has been paid to the inclination of
5-ALA for inducing protoporphyrin IX (PpIX) in tumor cells after
its exogenous administration. It has been used to detect and/or
facilitate the photodestruction of malignant tissue and in the
preoperative delineation of malignant brain tumors due to its
fluorescence and photosensitizing properties, which can help
lengthen patient survival.14,15 The recent strategies in PDT
(photodynamic therapy) for patients include prescribing 5-ALA
and/or alkyl esters, through one of three approaches, namely by
direct injection into the tissue, by administration in the blood, or
by topical application to the skin.16,17 Recently, a broad variety
of investigations has been performed upon the electrical and
structural properties of pure and functionalized 5-ALA. For
instance, Eriksson and Erdtman carried out a theoretical study
of 5-aminolevulinic acid and some pharmaceutically important
derivatives.14 Ganji et al. carried out a DFT study on the
interaction of the B36N36 cluster with glycine amino acid.
18
Gou and co-workers19 performed DFT calculations to investi-
gate the noncovalent functionalization of BN nanotubes with
perylene derivative molecules. Xie et al. experimentally found
that BN nanotubes can be functionalized with amino-based
systems. Regarding the noncovalent functionalizations of
BNNTs by aromatic compounds, surfactants, and polymers,
p–p stacking interactions have drawn increasing attention due
to their potential applications in upgrading novel biosensors, and
as biofunctional materials, nanovectors for cell therapy, and in
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drug and gene delivery systems.20 Zhao and Ding used theoretical
calculations to investigate the interaction of the noncovalent
functionalization of BN nanotubes by various aromatic
molecules.21 Zhi et al. studied how BN nanotubes could be
noncovalently functionalized by wrapping them with DNA.22
Very recently, Ciofani et al. experimentally investigated how BN
nanotubes could be coated by polyethyleneimine (PEI), indicat-
ing the essential stipulations for the biomedical applications of
BN nanotubes.12 In previous theoretical work,23 we performed
the interaction of 5-ALA drug with carbon nanostructures using
DFT calculations. Herein, we aimed to consider the electronic
and structural properties of 5-ALA functioned with B12N12 and
B16N16 nanoclusters to further understand B12N12 and B16N16
capacity for use in drug delivery applications.
2. Computational methods
Geometry optimizations, density of states (DOS), frontier mole-
cular orbital (FMO), and natural bond orbital (NBO) analyses
were performed with the GAMESS quantum chemistry software
package.24 All the calculations were based on the density
functional theory (DFT) and time-dependent density functional
theory (TD-DFT) with the B3LYP method with the standard
6-311+G** basis set.25 B3LYP is indicated to be a dependable
and usually applied functional in the study of diﬀerent BN
nanostructures.26–28 We utilized the exchange–correlation func-
tional parameterized by PBE and B3PW91 with superposition
error (BSSE) correction.29,30 In the PCM calculations, water was
used as a solvent, with a value of e = 78.4 for the dielectric
constant. Adsorption calculations were carried out in gaseous
and aqueous environments at T = 298.15 and 310.15 K. After
optimization, the obtained B–N bond length of B12N12 was
found to be about 1.486, 1.493, and 1.492 Å, and are 1.473,
1.481, and 1.480 Å in a 4-cycle for the B16N16 cage with the
B3LYP, PBE, and B3PW91 methods, respectively (see Table 1).
The adsorption energies (Ead) of 5-AVA on the pure BN nano-
cages are represented by:
Ead = Ecage–molecule  (Ecage + Emolecule) + EBSSE (1)
where Ecage is the adsorption energies of the pristine B12N12 and
B16N16 nanocages. Ecage–molecule is the adsorption energy of
5-AVA interacting with the pristine B12N12 and B16N16 clusters,
and Emolecule represents the energy of an isolated 5-AVA mole-
cule. The quantum molecular descriptors31,32 for the nanocage
were determined as follows:
m = (I + A)/2 (2)
w = m (3)
Z = (I  A)/2 (4)
S = 1/2Z (5)
o = (m2/2Z) (6)
The electronegativity (w) is defined as the negative of the
chemical potential (m), as follows: w = m. Furthermore, the
global hardness (Z) can be determined using the Koopmans’
theorem. I(EHOMO) is the ionization potential and A(ELUMO)
is the electron aﬃnity of the molecule.
3. Results and discussion
Initially, we computationally optimized the geometry of an
individual 5-aminolevulinic acid molecule (5-AVA) within the
gas phase; see Fig. 1 and Table 2. All the nitrogen and oxygen
atoms form essentially a planar structure with carbon atoms
implying sp2 orbital hybridization, thus maintaining the aro-
matic characteristics. Fig. 1a–c indicate the molecular electro-
static potential (MEP), the highest occupied molecular orbital
(HOMO), and the lowest unoccupied molecular orbital (LUMO)
of a 5-aminolevulinic acid molecule. It is apparent that the
electron densities in the HOMO and LUMO are situated on the
amine and carbonyl orbitals of the molecule and on the CH2
group. The energy gap (Eg) and Fermi level (EF) of the 5-amino-
levulinic acid molecule are 2.21 and 3.57 eV with the B3LYP
method, respectively. This result reveals that the 5-aminolevulinic
Table 1 Calculated structural and electronic properties of the B12N12 and
B16N16 nanocages with the B3PW91, B3LYP, and PBE methods
B3LYP B3PW91 PBE
System B12N12 B16N16 B12N12 B16N16 B12N12 B16N16
RB–N/Å 1.486 1.473 1.485 1.471 1.494 1.481
RB–N–B/1 80.50 78.53 80.12 78.15 79.95 77.85
RN–B–N/1 98.23 99.34 98.44 99.56 98.58 99.81
RN–B–N/1
QB/e 0.450 0.44 0.459 0.482 0.387 0.389
QN/e 0.450 0.44 0.459 0.482 0.387 0.390
EHOMO/eV 7.85 7.38 7.98 7.56 6.91 6.49
ELUMO/eV 1.11 1.01 1.05 1.10 1.92 1.88
Eg/eV 6.74 6.37 6.93 6.46 4.99 4.61
EFL/eV 4.48 4.20 4.52 4.33 4.42 4.19
m/eV 4.48 4.19 4.52 4.33 4.42 4.19
Z/eV 3.37 3.19 3.47 3.23 2.50 2.31
o/eV 2.98 2.76 2.94 2.90 3.91 3.80
S/eV 0.15 0.16 0.14 0.15 0.20 0.22
w/eV 4.48 4.19 4.52 4.33 4.42 4.19
DM/Debye 0.00 0.0 0.0 0.0 0.0 0.0
Fig. 1 The profiles of HOMO (a), LUMO (b), and MEP (c) of 5-amino-
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acid molecule with a large energy gap is a hard molecule.31 Also,
the dipole moment (DM) of this drugmolecule is about 2.27 Debye.
The relaxed geometries of the 5-AVA–B12N12 and 5-AVA–B16N16
systems with the B3LYP method are shown in Fig. 2A–C and 3A–C.
To evaluate the preferred interaction, the interaction of the 5-AVA
drug with the boron atoms of the B12N12 and B16N16 clusters was
studied. The chemisorption energy of the 5-AVA molecule from
its –NH2 group close to the B12N12 and B16N16 clusters was
calculated to be 1.33 and 1.20 eV, respectively (see Table 3).
The distances of the drug molecule with the NH2 group
attached to the B atoms of the B12N12 and B16N16 nanoclusters
are 1.629 and 1.638 Å, respectively. NBO reveals that notable
charge transfers occurred of 0.337 and 0.274 electrons from the
5-AVA molecule as a donor to the B12N12 and B16N16 nano-
clusters. We noted that the interaction of 5-AVA drug on the
B12N12 cluster has the largest adsorption energy, while the
interaction of this drug molecule with the B16N16 nanocluster
is the smallest (see Fig. 3A–C).
Table 2 Results obtained from geometry optimizations of the 5-aminolevulinic acid molecule in the B3LYP method
System RC–N/Å RC–H/Å RC–O/Å RO–H/Å RC–C–C/1 RC–C–N/1 RN–C–C–C/1 RC–C–C–C/1
RB–N/Å 1.452 1.095 1.212 0.964 116.6 116.1 179.6 179.5
Fig. 2 Optimized structures and the electronic density of states of
5-aminolevulinic acid over the B12N12 nanocage.
Fig. 3 Optimized structures and the electronic density of states of















































This journal is©The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2016 New J. Chem., 2016, 40, 7018--7026 | 7021
Then, we compared the present studies with the adsorption
of the 5-AVA molecule to the pristine carbon nanostructures in
the previous reports.23 The calculated binding energy of the
5-AVA molecule in the active sites, including NH2 and CO
groups interacting with the C24 nanocage, is about 0.79 and
0.89 eV, with the B3LYP method, respectively. Based on this
research, the interaction energy of the 5-AVA molecule with the
carbon nanocage is significantly unstable in terms of its active
sites in comparison with that of the BN nanocages. Based on
the acquired results, the B–N bond length and N–B–N angle of
the 5-AVA/B12N12 complex were found to be 1.564 Å and 92.151,
while for the 5-AVA/B16N16 complex the same were 1.569 Å and
93.151, respectively. Upon the interaction, the N–H bond length
and H–N–H angle of the 5-AVA molecule are 1.024 Å and
105.021, respectively. The bond lengths of C–N and C–O in
the pure 5-AVA molecule are 1.453 and 1.219 Å with the B3LYP
method, respectively. Erdtman and Eriksson14 showed that the
C–N and C–O lengths of the 5-AVA molecule are about 1.457
and 1.226 Å at the B3LYP/6-31+G* level, respectively, which is
comparable with our results. The calculated binding energies of
the 5-AVA molecule from its OH group with the two systems,
including the B12N12 and B16N16 nanoclusters, are 0.23 and
0.20 eV with the distances of 1.82 and 2.01 Å, respectively.
Anota and Cocoletzi33 showed the adsorption between the
metformin molecule and (5, 5) BNNT, with an energy value of
0.63 eV, which is a result of the exothermic process. We also
calculated the adsorption of the 5-AVA molecule in the most
stable configuration (from its NH2 group) toward B12N12 and
B16N16 clusters at the PBE functional (see Table 4). The binding
energies acquired for the 5-AVA molecule (NH2 group) on the B
atoms of the B12N12 and B16N16 clusters are included with the
exothermic adsorption energies of 1.49 and 1.38 eV, respec-
tively. These are very different from the above theoretical
values (with the B3LYP method). The smaller atomic distances
between the N atom of the molecule and the B atoms of the
B12N12 and B16N16 clusters are 1.630 and 1.638 Å, respectively.
Besides, the interaction of the 5-AVA molecule with BN
nanoclusters with the PBE method indicates a considerable
reduction in adsorption energy compared with the B3LYP
method. The N–H bond lengths in the 5-AVA molecule added
to the B12N12 and B16N16 clusters were 1.036 and 1.031 Å,
respectively, which are larger than the isolated 5-AVA bond
length (N–H = 1.023 Å); whereas the B–N lengths of the B12N12
and B16N16 clusters after the adsorption of the 5-AVA molecule
were found to be 1.576 and 1.554 Å, respectively. Therefore,
we considered that the covalent interaction at the above-
mentioned separation will be strong in nature. MPA reveals
that notable charge transfers are occurring in terms of 0.321
and 0.320 electrons from the 5-AVA molecule to the B12N12 and
B16N16 clusters with the PBE functional. These results clearly
show that the charge transfer occurring for both systems are
almost the same. Ganji et al. introduced the binding energy of a
glycine molecule adsorbed upon the B36N36 cage with an energy
value of 1.15 eV in the PBE method.18 In contrast, when the
5-AVA molecule adsorbed on the B12N12 and B16N16 nanoclus-
ters in the PBE method, it exhibited that the binding energies
for both two systems were reduced with notable changes, as
compared with that in B3LYP method. The adsorption energies
of the isoniazid drug upon the (5, 5) and (10, 0) BN nanotubes
have been reported with the values of 0.649 and 0.738 eV
Table 3 Calculated structural and electronic properties of 5-aminolevulinic















RB–N/Å 1.515 1.548 1.539 1.553 1.488 1.486
RB–N–B/1 83.80 84.35 82.45 82.13 79.34 78.10
RN–B–N/1 92.15 92.40 94.29 93.15 98.20 99.12
RN–B–N/1
RNH2/Å 1.023 1.018 1.019 1.023 1.019 1.020
RCO/Å 1.218 1.244 1.218 1.218 1.224 1.220
ROH/Å 0.972 0.972 0.980 0.972 0.972 0.981
D/Å 1.629 1.616 1.822 1.638 2.310 2.016
Ead/eV 1.33 0.48 0.23 1.20 0.42 0.20
QB/e 0.628 0.621 0.601 0.652 0.558 0.499
QN/e 0.515 0.545 0.524 0.510 0.491 0.552
QNH2–AVA/e 0.693 0.681 0.682 0.710 0.704 0.684
QCO–AVA/e 0.446 0.387 0.394 0.446 0.433 0.457
QOH–AVA/e 0.561 0.557 0.610 0.561 0.567 0.614
EHOMO/eV 6.84 6.93 6.91 6.59 6.85 6.53
ELUMO/eV 1.86 2.86 1.28 1.91 1.44 1.29
Eg/eV 4.98 4.07 5.63 4.68 5.41 5.24
DEg (%) 27.20 40.58 17.69 26.5 20.91 23.39
EFL/eV 4.35 4.90 4.10 4.25 4.15 3.91
m/eV 4.35 4.90 4.10 4.25 4.15 3.91
Z/eV 2.49 2.04 2.82 2.34 2.71 2.62
o/eV 3.80 5.89 2.98 3.86 3.18 2.92
S/eV 0.20 0.25 0.18 0.21 0.18 0.19
w/eV 4.35 4.90 4.10 4.25 4.15 3.91
DM/Debye 7.67 6.57 5.66 7.40 1.197 3.99
Table 4 Calculated structural and electronic properties of the 5-amino-
levulinic acid molecule interacting with the B12N12 and B16N16 nanocages















RB–N/Å 1.566 1.545 1.541 1.576 1.575 1.552
RB–N–B/1 83.37 84.17 82.89 83.39 84.20 82.15
RN–B–N/1 92.24 92.58 94.20 92.29 92.57 94.32
RNH2/Å 1.021 1.014 1.015 1.032 1.023 1.025
RCO/Å 1.210 1.237 1.209 1.223 1.252 1.222
ROH/Å 0.963 0.963 0.970 0.974 0.975 0.981
D/Å 1.617 1.613 1.775 1.630 1.622 1.797
Ead/eV 1.39 0.51 0.23 1.49 0.63 0.32
QB/e 0.548 0.524 0.563 0.472 0.432 0.471
QN/e 0.398 0.430 0.409 0.347 0.375 0.361
QN–AVA/e 0.385 0.439 0.442 0.362 0.408 0.414
QCO–AVA/e 0.310 0.237 0.310 0.271 0.191 0.265
QOH–AVA/e 0.303 0.299 0.375 0.263 0.260 0.321
ESOMO/eV 7.15 7.22 7.14 6.08 6.17 5.91
ELUMO/eV 2.01 2.98 1.49 2.96 3.85 2.42
Eg/eV 5.14 4.24 5.66 3.12 2.32 3.49
DEg (%) 25.83 38.82 18.33 37.47 53.51 30.06
EFL/eV 4.58 5.10 4.32 4.52 5.01 4.17
m/eV 4.58 5.10 4.32 4.52 5.01 4.17
Z/eV 2.57 2.12 2.83 1.56 1.16 1.75
o/eV 4.08 6.13 3.30 6.55 10.82 4.97
S/eV 0.19 0.24 0.18 0.32 0.43 0.29
w/eV 4.58 5.10 4.32 4.52 5.01 4.17
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with the PBE functional, respectively.34 The adsorption energy
of the 5-AVA molecule is close to that of the B12N12 nanocluster,
therefore it appears to be stronger than those in the 5-AVA
molecule interacting with the B16N16 nanocluster. When con-
sidering the 5-AVA molecule from its NH2 group interaction
with the B atoms of the B12N12 and B16N16 clusters, the values
of the electric dipole moment are significantly increased from
0.0 Debye in the pure structures to 7.67 and 7.40 Debye in the
complexes in the PBE method, respectively. As calculated by the
PBE method, the dipole moment values for 5-AVA approaching
the B12N12 and B16N16 nanoclusters significantly increased from
zero in the pure structures to 7.48 and 7.40 Debye in the complex
configurations, respectively. In other words, we consider the
interaction of 5-AVA with B12N12 and B16N16 nanoclusters with
the contact values of 1.623 and 1.630 Å in the B3PW91 func-
tional. It was found that the adsorption of the 5-AVA molecule
with the B12N12 and B16N16 clusters is exothermic, with the high
negative values of 1.39 and 1.30 eV, respectively. The high
negative Ead of the 5-AVA drug on the exterior surfaces of the
B12N12 and B16N16 nanoclusters indicates the chemical nature
of the interaction. NBO reveals that notable charge transfers are
occurring in 0.304 and 0.299 electrons from the 5-AVA molecule
to the B12N12 and B16N16 nanoclusters in the B3PW91 func-
tional. In the adsorption process between the adsorbate and
adsorbent, a local structural deformation is attributed to the
change from sp2 to sp3 hybridization of the B atom, where the
sidewall boron atom is significantly pulled out of the surface
(by about 0.1 Å), indicating that the interaction is mainly
covalent in nature. The DM for 5-AVA molecule close to the
B12N12 and B16N16 clusters is significantly increased to 7.48 and
7.34 Debye in the B3PW91 functional, respectively (Table 4).
Fig. 4 indicates the HOMO (highest occupied molecular
orbital) and LUMO (lowest unoccupied molecular orbital)
profiles for the 5-AVA molecule (NH2 group) toward the
B12N12 nanocluster. These profiles represent that the HOMO
orbital is mainly localized on the nanocage and the LUMO
orbital is localized on the drug molecule. As shown in Fig. 4, the
LUMO+1, LUMO+2, and LUMO+3 are located at the higher
energy levels compared to the LUMO, while the HOMO3 is
located at the lower energy level compared to the HOMO. These
profiles imply that the value of Ead in HOMO–LUMO orbital
interactions depends on the overlap and energy match between
the mixing orbitals, and suggests that a greater energy discre-
pancy between the interacting HOMO and LUMO leads to
higher Ead.
The adsorption behavior of the 5-AVA molecule toward
B12N12 nanocluster under diﬀerent temperatures (from 298.15
to 311.15 K) in the gas phase was studied (Table 5). The results
indicate that the adsorption energy initially decreases with
increasing temperature. As a result, the highest adsorption
energy can be observed at 298.15 K, and the lowest minimum
adsorption energy can be obtained at 398.15 K. The adsorption
energies between the 5-AVA molecule and B12N12 cluster at the
temperature of 398.15 K were calculated to be 1.37, 1.45,
and 1.54 eV in the B3LYP, B3PW91, and PBE methods,
respectively, suggesting that the adsorption behaviors of drug
molecule are exothermic processes. The diﬀerent energy dis-
tribution found in adsorption behavior at 398.15 K has no eﬀect
on the distance between the drug molecule and adsorbent
(1.629, 1.623, and 1.631 Å in the B3LYP, B3PW91, and PBE,
respectively). Solvation energies (Esolv) of the pure B12N12 inter-
acting with the 5-AVA molecule have been studied in the B3LYP,
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B3PW91, and PBE methods for optimizing the structures in a
vacuum and in water compared to that in the gas phase (see
Table 6). The diﬀerence between these optimization energies
equals Esolv. The solvation energies were computed with the aid
of the ‘Conductor-like Screening Model’ for solvation.31 A more
negative Esolv will result in a higher degree of solubility. The
solvation energy values of the 5-AVA drug molecule were
calculated to be 0.38, 0.39, and 0.34 eV in the B3LYP,
B3PW91, and PBE methods, respectively. Esolv values for the
5-AVA drug with the B12N12 nanocage were about 1.42, 1.51,
and 1.59 eV in the B3LYP, B3PW91, and PBE methods,
respectively. On loading 5-AVA drug molecule toward the
B12N12 nanocage, Esolv gets a further deduction, thus showing
an increase in the solubility of the drug molecule in the
presence of solvent. The molecular electrostatic potential
(MEP) maps for the 5-AVA molecule interacting with the
B12N12 and B16N16 clusters were studied (Fig. 5). MEP maps
indicate that in the adsorption of a drug molecule, clusters are
positively charged (blue color with low intensity) while the N
atoms are negatively charged (red color with high intensity) and
the B atoms are positively charged (blue color) in the B–N
bonds of the cluster, therefore, the drug molecule functions as
an electron donor and the cluster functions as an electron
acceptor owing to a strong adsorption. The semiconducting
properties of the B12N12 and B16N16 nanoclusters with energy
gaps of about 6.74 and 6.37 eV, respectively, can be seen in the
computed DOS plots from using the B3LYP method, as shown
in Fig. 3. Whereas the energy gaps of the B12N12 and B16N16
clusters were calculated to 4.99 and 4.61 eV with the PBE
method, respectively, these represent values significantly
smaller than the Eg in the B3LYP method. The energy gap of
the B12N12 cluster was experimentally computed with the value
of 5.1 eV by Oku and coworkers.35 This result is in agreement
with the DFT calculation reported by Baei et al.36 The Eg values
of the B12N12 and B16N16 clusters are about 6.93 and 6.46 eV
with the B3PW91 functional, respectively. With the adsorption
of 5-AVA molecule in the B3PW91 method, the energy gaps of
the B12N12 and B16N16 clusters are significantly reduced to
5.14 and 5.68 eV, respectively. Whereas the energy gaps of the
5-AVA molecule interacting with the B12N12 and B16N16 clusters are
decreased to 3.12 and 3.56 eV in the PBE method, respectively. We
found that the calculations of Eg from both configurations in the
PBE method were closer to the results of the theoretical data, as
mentioned above by Baei et al.36 The calculations of energy gap
obtained by the PBE and B3PW91 methods are significantly
smaller than those obtained by the B3LYP method.
The quantum molecular descriptors (QMD) of reactivity in
the context of DFT calculations are summarized in Tables 2–5.
Table 5 Calculated structural and electronic properties of 5-aminolevulinic
acid molecule interacting with the B12N12 and B16N16 nanocages at tempera-




B12N12 B12N12 AVA/B12N12 B12N12
AVA/
B12N12
RB–N/Å 1.487 1.565 1.485 1.565 1.494 1.573
RB–N–B/1 80.50 83.81 80.12 83.80 79.94 83.45
RN–B–N/1 98.23 92.09 98.44 92.15 98.58 92.53
D/Å — 1.629 — 1.629 — 1.631
Ead/eV — 1.18 — 1.26 — 1.34
QB/e 0.440 0.631 0.459 0.629 0.387 0.532
QN/e 0.440 0.517 0.459 0.517 0.387 0.456
QN–AVA/e — 0.691 — 0.696 — 0.676
EHOMO/eV 7.71 6.85 7.89 7.0 6.78 5.89
ELUMO/eV 0.87 1.84 0.90 1.91 1.72 2.83
Eg/eV 6.84 5.01 6.99 5.09 5.06 3.06
DEg (%) — 26.75 — 27.18 — 39.52
EFL/eV 4.29 4.35 4.40 4.46 4.25 4.36
m/eV 4.29 4.35 4.40 4.46 4.25 4.36
Z/eV 3.42 2.51 3.50 2.55 2.53 1.53
o/eV 2.69 3.77 2.76 3.90 3.57 6.21
S/eV 0.15 0.20 0.14 0.20 0.20 0.33
w/eV 4.29 4.35 4.40 4.46 4.25 4.36
DM/Debye 0.00 7.89 0.00 7.57 0.00 7.58
Table 6 Calculated structural and electronic properties of 5-aminolevulinic
acid molecule interacting with the B12N12 and B16N16 nanocages in the solvent
phase
B3LYP (H2O) B3PW91 (H2O) PBE (H2O)
System B12N12
AVA/
B12N12 B12N12 AVA/B12N12 B12N12
AVA/
B12N12
RB–N/Å 1.486 1.578 1.484 1.574 1.494 1.583
RB–N–B/1 80.54 83.96 80.11 83.62 79.95 83.63
RN–B–N/1 98.18 91.24 98.46 91.60 98.60 91.64
D/Å — 1.606 — 1.601 — 1607
Ead/eV 0.38 1.42 0.39 1.51 0.34 1.59
QB/e 0.449 0.652 0.469 0.648 0.396 0.548
QN/e 0.449 0.509 0.469 0.522 0.396 0.447
QN–AVA/e — 0.705 — 0.743 — 0.685
EHOMO/eV 7.70 6.96 7.87 7.12 6.77 6.02
ELUMO/eV 0.80 1.07 0.83 1.13 1.66 2.11
Eg/eV 6.90 5.89 7.04 5.99 5.11 3.91
DEg (%) — 14.64 — 14.91 — 23.48
EFL/eV 4.25 4.02 4.35 4.13 4.22 4.07
m/eV 4.25 4.02 4.35 4.13 4.22 4.07
Z/eV 3.45 2.95 3.52 2.99 2.56 1.96
o/eV 2.62 2.74 2.69 2.84 3.48 4.23
S/eV 0.14 0.17 0.14 0.17 0.19 0.26
w/eV 4.25 4.02 4.35 4.13 4.22 4.07
DM/Debye 0.00 10.26 0.00 10.27 0.00 9.72
Fig. 5 The molecular electrostatic potential of 5-aminolevulinic acid
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When the 5-AVA molecule (NH2 group) was adsorbed on to the
B12N12 nanocluster, the hardness values were reduced from
3.37, 3.47, and 2.50 eV in the pristine cluster to 2.49, 2.57, and
1.56 eV in the complexes in the B3LYP, B3PW91, and PBE
methods, respectively, which means that the stabilities of the
complexes are lower than the pristine clusters.37,38 The electro-
philicity index of the drug molecule interacting with the B12N12
cluster was drastically higher, with values from 2.98, 2.94, and
3.91 eV in the pristine cluster to 3.80, 4.08, and 6.55 eV in the
complexes in the B3LYP, B3PW91, and PBE methods, respec-
tively, indicating the higher electrophilicity of the molecule,
which is greater than its electrophile character (see Tables 1–3).
TD-DFT calculations for the 5-AVA drug molecule interacting
with the B12N12 nanocluster were performed.
39 The details of
these calculations are listed in Table 7. According to this
Table 7, the 5-AVA drug molecule has two excited states at the
wavelengths of 400.01 and 394.01 nm with oscillator strengths
( f ) of 0.0015 and 0.0069 (in the PBE method), respectively.
The transition from HOMO1 to LUMO is observed with a
value of 0.0069 of the oscillator strength and a transition energy
of 3.15 eV. Two main transitions for the drug molecule in the
B3LYP method were observed at wavelengths of 278.26 and
275.06 nm, with oscillator strengths of 0.0019 and 0.0049,
respectively. At l = 275.06 nm, an electron is transferred from
HOMO1 to LUMO, mainly arising from p - p* electronic
excitations,40,41 with 0.0049 oscillator strength and a transition
energy of 4.51 eV. The B3PW91 method involved two bands at
272.32 and 269.14 nm, with f values of 0.00298 and 0.0033,
respectively. At a wavelength of 269.14 nm, electron transfer
occurred from HOMO1 to LUMO, which involved 66% as the
main transition. The UV-Vis absorption spectrum of the 5-AVA
drug molecule on the BN nanoclusters is shown in Fig. 6, with
different basis sets. The UV-Vis absorption spectrum from the
PBE method exhibits a strong band at 394.01 nm. However, the
B3LYP method shows a band at 275.06 nm, while also the
UV-Vis absorption spectrum from the B3PW91 method exhibits
a band at 269.14 nm. Tables 2 and 3 present the results, which
show the four highest and the four lowest molecular orbital
energy levels of the 5-AVA drug molecule on the BN nanoclusters.
Note that the HOMO–LUMO gap of the PBE method is relatively
smaller than in the other methods.
Focus was placed on the photoinjection mechanisms from
the excited electronic states of the 5-AVA drug molecule with
the B12N12 nanocluster. Surface sensitization involved the
adsorption of a 5-AVA drug molecule to the BN nanocluster
surface and the formation of a 5-AVA-BN nanocluster surface
compound. Photoexcitation of the surface compound can lead
to interfacial electron transfer when there is a suitable energy
match between the photoexcited electronic state in the surface
compound and the electronic states in the HOMO–LUMO gap
of the BN cluster. Injection times as short as a few femto-
seconds were investigated for various systems. According to
Fig. 7, the time for electron injection in the 5-AVA drug molecule
Table 7 Selected excitation energies (eV, nm), oscillator strength (f ), and







strength ( f ) Assignment
B3LYP
4.55 278.26 0.0019 H- L (96%)
4.51 275.06 0.0049 H10- L (12%),
H1- L (82%)
B3PW91 H- L (91%),
H10- L (4%)
4.55 272.32 0.0029 H10- L (21%),
H1- L (66%)
4.61 269.14 0.0033 H6- L (3%),
H- L (3%)
PBE
3.09 400.01 0.0015 H- L (99%)
3.15 394.01 0.0069 H1- L (99%)
Fig. 6 UV-Vis spectra of the 5-aminolevulinic acid molecule (NH2 group)
on the B12N12 nanocages.
Fig. 7 Time-dependent survival probability in a sensitized B12N12 nano-
cage. The dashed lines are the exponential fitting curves to the two
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was approximately 10 fs in the B12N12 cluster. Fig. 8 shows the
evolution of the time-dependent charge distribution during the
early time relaxation dynamics after instantaneously populating
the 5-AVA-LUMO, including the primary electron-transfer event,
within the first 2 fs of dynamics.
4. Concluding remarks
To conclude, we investigated the binding and electronic proper-
ties of the covalent functionalization of B12N12 and B16N16 clusters
with 5-aminolevulinic acid drug using DFT calculations. We
found that the 5-AVA (NH2 group) could be drug-loaded and
covalently attached to B12N12 and B16N16 nanoclusters with almost
similar binding energies of 2.01 and 1.95 eV in the B3LYP
method, respectively, while the apparent results of the B3LYP
method are fully diﬀerent compared with the B3PW91 and PBE
methods. The functionalization of the B12N12 and B16N16 clusters
with 5-AVA drug indicate their considerable influence in the
electronic properties of the adsorbent. NBO analysis predicted a
significant charge transfer from the drug molecule to the
adsorbents. We hope our results of the adsorption properties
of 5-aminolevulinic acid on B12N12 and B16N16 nanoclusters can
be used as in the adsorbent enhancing delivery of drugs to
cancer cells and to support decreased drug interaction with
healthy tissue.
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